Status:
COMPLETED
N-acetyl Cysteine: the Effectiveness and Safety in a Cohort of Pediatric Patients With Chronic Kidney Disease
Lead Sponsor:
Beni-Suef University
Collaborating Sponsors:
Cairo University
Conditions:
Chronic Kidney Diseases
Eligibility:
All Genders
6-18 years
Phase:
PHASE2
Brief Summary
Anemia is a common comorbidity of CKD and is associated with a decreased quality of life and increased healthcare resource utilization. Anemia increases the risk of CKD progression, cardiovascular com...
Detailed Description
All patients with chronic kidney disease on regular hemodialysis will be enrolled. \- Study location: The patients will be recruited from pediatric nephrology department, Cairo University Children's ...
Eligibility Criteria
Inclusion
- pediatric patients with chronic kidney diseases stage 3, 4 or 5
Exclusion
- Unwilling to participate in the study.
- non-compliant patients on the standard care of CKD.
- Patients with cardiac, endocrinal, and hepatic complications.
- Asthma or known allergy to NAC.
- Any chronic infections prior to or during the study period.
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04916080
Start Date
November 1 2021
End Date
January 1 2023
Last Update
April 11 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beni-Suef university hospital
Banī Suwayf, Egypt, 65211
2
Pediatric nephrology and transplantation unite.Aboelrish children hospital
Cairo, Egypt